Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) 3D Printed Drugs Market 2018, Forecast to 2023

  • receipt Report ID : 137296
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 133
  • list Pharmaceuticals and Healthcare

3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. 

Scope of the Report:

This report focuses on the 3D Printed Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Spritam is the only 3D printed drug which has received FDA approval. This drug was first available in the market in 2016, and can be used to treat epilepsy. 

The worldwide market for 3D Printed Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.

Market Segment by Manufacturers, this report covers

Aprecia Pharmaceuticals

GlaxoSmithKline Plc

Hewlett Packard Caribe

BV

LLC

3D Printer Drug Machine

FabRx Ltd

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Spritam

Others

Market Segment by Applications, can be divided into

Children

Elderly

Others

There are 15 Chapters to deeply display the global 3D Printed Drugs market.

Chapter 1, to describe 3D Printed Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of 3D Printed Drugs, with sales, revenue, and price of 3D Printed Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of 3D Printed Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, 3D Printed Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe 3D Printed Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 3D Printed Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Spritam

1.2.2 Others

1.3 Market Analysis by Applications

1.3.1 Children

1.3.2 Elderly

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Aprecia Pharmaceuticals

2.1.1 Business Overview

2.1.1.1 Aprecia Pharmaceuticals Description

2.1.1.2 Aprecia Pharmaceuticals Headquarter, Main Business and Finance Overview

2.1.2 Aprecia Pharmaceuticals 3D Printed Drugs Product Introduction

2.1.2.1 3D Printed Drugs Production Bases, Sales Regions and Major Competitors

2.1.2.2 3D Printed Drugs Product Information

2.1.3 Aprecia Pharmaceuticals 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.3.1 Aprecia Pharmaceuticals 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.3.2 Global Aprecia Pharmaceuticals 3D Printed Drugs Market Share in 2017

2.2 GlaxoSmithKline Plc

2.2.1 Business Overview

2.2.1.1 GlaxoSmithKline Plc Description

2.2.1.2 GlaxoSmithKline Plc Headquarter, Main Business and Finance Overview

2.2.2 GlaxoSmithKline Plc 3D Printed Drugs Product Introduction

2.2.2.1 3D Printed Drugs Production Bases, Sales Regions and Major Competitors

2.2.2.2 3D Printed Drugs Product Information

2.2.3 GlaxoSmithKline Plc 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.3.1 GlaxoSmithKline Plc 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.3.2 Global GlaxoSmithKline Plc 3D Printed Drugs Market Share in 2017

2.3 Hewlett Packard Caribe

2.3.1 Business Overview

2.3.1.1 Hewlett Packard Caribe Description

2.3.1.2 Hewlett Packard Caribe Headquarter, Main Business and Finance Overview

2.3.2 Hewlett Packard Caribe 3D Printed Drugs Product Introduction

2.3.2.1 3D Printed Drugs Production Bases, Sales Regions and Major Competitors

2.3.2.2 3D Printed Drugs Product Information

2.3.3 Hewlett Packard Caribe 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.3.1 Hewlett Packard Caribe 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.3.2 Global Hewlett Packard Caribe 3D Printed Drugs Market Share in 2017

2.4 BV

2.4.1 Business Overview

2.4.1.1 BV Description

2.4.1.2 BV Headquarter, Main Business and Finance Overview

2.4.2 BV 3D Printed Drugs Product Introduction

2.4.2.1 3D Printed Drugs Production Bases, Sales Regions and Major Competitors

2.4.2.2 3D Printed Drugs Product Information

2.4.3 BV 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.3.1 BV 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.3.2 Global BV 3D Printed Drugs Market Share in 2017

2.5 LLC

2.5.1 Business Overview

2.5.1.1 LLC Description

2.5.1.2 LLC Headquarter, Main Business and Finance Overview

2.5.2 LLC 3D Printed Drugs Product Introduction

2.5.2.1 3D Printed Drugs Production Bases, Sales Regions and Major Competitors

2.5.2.2 3D Printed Drugs Product Information

2.5.3 LLC 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.3.1 LLC 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.3.2 Global LLC 3D Printed Drugs Market Share in 2017

2.6 3D Printer Drug Machine

2.6.1 Business Overview

2.6.1.1 3D Printer Drug Machine Description

2.6.1.2 3D Printer Drug Machine Headquarter, Main Business and Finance Overview

2.6.2 3D Printer Drug Machine 3D Printed Drugs Product Introduction

2.6.2.1 3D Printed Drugs Production Bases, Sales Regions and Major Competitors

2.6.2.2 3D Printed Drugs Product Information

2.6.3 3D Printer Drug Machine 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.3.1 3D Printer Drug Machine 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.3.2 Global 3D Printer Drug Machine 3D Printed Drugs Market Share in 2017

2.7 FabRx Ltd

2.7.1 Business Overview

2.7.1.1 FabRx Ltd Description

2.7.1.2 FabRx Ltd Headquarter, Main Business and Finance Overview

2.7.2 FabRx Ltd 3D Printed Drugs Product Introduction

2.7.2.1 3D Printed Drugs Production Bases, Sales Regions and Major Competitors

2.7.2.2 3D Printed Drugs Product Information

2.7.3 FabRx Ltd 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7.3.1 FabRx Ltd 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7.3.2 Global FabRx Ltd 3D Printed Drugs Market Share in 2017

3 Global 3D Printed Drugs Market Competition, by Manufacturer

3.1 Global 3D Printed Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global 3D Printed Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Global 3D Printed Drugs Price by Manufacturer (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 3D Printed Drugs Manufacturer Market Share in 2017

3.4.2 Top 5 3D Printed Drugs Manufacturer Market Share in 2017

3.5 Market Competition Trend

4 Global 3D Printed Drugs Market Analysis by Regions

4.1 Global 3D Printed Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global 3D Printed Drugs Sales by Regions (2013-2018)

4.1.2 Global 3D Printed Drugs Revenue by Regions (2013-2018)

4.2 North America 3D Printed Drugs Sales, Revenue and Growth Rate (2013-2018)

4.3 Europe 3D Printed Drugs Sales, Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific 3D Printed Drugs Sales, Revenue and Growth Rate (2013-2018)

4.5 South America 3D Printed Drugs Sales, Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa 3D Printed Drugs Sales, Revenue and Growth Rate (2013-2018)

5 North America 3D Printed Drugs by Countries, Type, Application and Manufacturers

5.1 North America 3D Printed Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America 3D Printed Drugs Sales by Countries (2013-2018)

5.1.2 North America 3D Printed Drugs Revenue by Countries (2013-2018)

5.1.3 United States 3D Printed Drugs Sales and Growth Rate (2013-2018)

5.1.4 Canada 3D Printed Drugs Sales and Growth Rate (2013-2018)

5.1.5 Mexico 3D Printed Drugs Sales and Growth Rate (2013-2018)

5.2 North America 3D Printed Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)

5.2.1 North America 3D Printed Drugs Sales by Manufacturers (2016-2017)

5.2.2 North America 3D Printed Drugs Revenue by Manufacturers (2016-2017)

5.3 North America 3D Printed Drugs Sales, Revenue and Market Share by Type (2013-2018)

5.3.1 North America 3D Printed Drugs Sales and Sales Share by Type (2013-2018)

5.3.2 North America 3D Printed Drugs Revenue and Revenue Share by Type (2013-2018)

5.4 North America 3D Printed Drugs Sales, Revenue and Market Share by Application (2013-2018)

5.4.1 North America 3D Printed Drugs Sales and Sales Share by Application (2013-2018)

5.4.2 North America 3D Printed Drugs Revenue and Revenue Share by Application (2013-2018)

6 Europe 3D Printed Drugs by Countries, Type, Application and Manufacturers

6.1 Europe 3D Printed Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe 3D Printed Drugs Sales by Countries (2013-2018)

6.1.2 Europe 3D Printed Drugs Revenue by Countries (2013-2018)

6.1.3 Germany 3D Printed Drugs Sales and Growth Rate (2013-2018)

6.1.4 UK 3D Printed Drugs Sales and Growth Rate (2013-2018)

6.1.5 France 3D Printed Drugs Sales and Growth Rate (2013-2018)

6.1.6 Russia 3D Printed Drugs Sales and Growth Rate (2013-2018)

6.1.7 Italy 3D Printed Drugs Sales and Growth Rate (2013-2018)

6.2 Europe 3D Printed Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)

6.2.1 Europe 3D Printed Drugs Sales by Manufacturers (2016-2017)

6.2.2 Europe 3D Printed Drugs Revenue by Manufacturers (2016-2017)

6.3 Europe 3D Printed Drugs Sales, Revenue and Market Share by Type (2013-2018)

6.3.1 Europe 3D Printed Drugs Sales and Sales Share by Type (2013-2018)

6.3.2 Europe 3D Printed Drugs Revenue and Revenue Share by Type (2013-2018)

6.4 Europe 3D Printed Drugs Sales, Revenue and Market Share by Application (2013-2018)

6.4.1 Europe 3D Printed Drugs Sales and Sales Share by Application (2013-2018)

6.4.2 Europe 3D Printed Drugs Revenue and Revenue Share by Application (2013-2018)

7 Asia-Pacific 3D Printed Drugs by Countries, Type, Application and Manufacturers

7.1 Asia-Pacific 3D Printed Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific 3D Printed Drugs Sales by Countries (2013-2018)

7.1.2 Asia-Pacific 3D Printed Drugs Revenue by Countries (2013-2018)

7.1.3 China 3D Printed Drugs Sales and Growth Rate (2013-2018)

7.1.4 Japan 3D Printed Drugs Sales and Growth Rate (2013-2018)

7.1.5 Korea 3D Printed Drugs Sales and Growth Rate (2013-2018)

7.1.6 India 3D Printed Drugs Sales and Growth Rate (2013-2018)

7.1.7 Southeast Asia 3D Printed Drugs Sales and Growth Rate (2013-2018)

7.2 Asia-Pacific 3D Printed Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)

7.2.1 Asia-Pacific 3D Printed Drugs Sales by Manufacturers (2016-2017)

7.2.2 Asia-Pacific 3D Printed Drugs Revenue by Manufacturers (2016-2017)

7.3 Asia-Pacific 3D Printed Drugs Sales, Revenue and Market Share by Type (2013-2018)

7.3.1 Asia-Pacific 3D Printed Drugs Sales and Sales Share by Type (2013-2018)

7.3.2 Asia-Pacific 3D Printed Drugs Revenue and Revenue Share by Type (2013-2018)

7.4 Asia-Pacific 3D Printed Drugs Sales, Revenue and Market Share by Application (2013-2018)

7.4.1 Asia-Pacific 3D Printed Drugs Sales and Sales Share by Application (2013-2018)

7.4.2 Asia-Pacific 3D Printed Drugs Revenue and Revenue Share by Application (2013-2018)

8 South America 3D Printed Drugs by Countries, Type, Application and Manufacturers

8.1 South America 3D Printed Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America 3D Printed Drugs Sales by Countries (2013-2018)

8.1.2 South America 3D Printed Drugs Revenue by Countries (2013-2018)

8.1.3 Brazil 3D Printed Drugs Sales and Growth Rate (2013-2018)

8.1.4 Argentina 3D Printed Drugs Sales and Growth Rate (2013-2018)

8.1.5 Colombia 3D Printed Drugs Sales and Growth Rate (2013-2018)

8.2 South America 3D Printed Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)

8.2.1 South America 3D Printed Drugs Sales by Manufacturers (2016-2017)

8.2.2 South America 3D Printed Drugs Revenue by Manufacturers (2016-2017)

8.3 South America 3D Printed Drugs Sales, Revenue and Market Share by Type (2013-2018)

8.3.1 South America 3D Printed Drugs Sales and Sales Share by Type (2013-2018)

8.3.2 South America 3D Printed Drugs Revenue and Revenue Share by Type (2013-2018)

8.4 South America 3D Printed Drugs Sales, Revenue and Market Share by Application (2013-2018)

8.4.1 South America 3D Printed Drugs Sales and Sales Share by Application (2013-2018)

8.4.2 South America 3D Printed Drugs Revenue and Revenue Share by Application (2013-2018)

9 Middle East and Africa 3D Printed Drugs by Countries, Type, Application and Manufacturers

9.1 Middle East and Africa 3D Printed Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa 3D Printed Drugs Sales by Countries (2013-2018)

9.1.2 Middle East and Africa 3D Printed Drugs Revenue by Countries (2013-2018)

9.1.3 Saudi Arabia 3D Printed Drugs Sales and Growth Rate (2013-2018)

9.1.4 UAE 3D Printed Drugs Sales and Growth Rate (2013-2018)

9.1.5 Egypt 3D Printed Drugs Sales and Growth Rate (2013-2018)

9.1.6 Nigeria 3D Printed Drugs Sales and Growth Rate (2013-2018)

9.1.7 South Africa 3D Printed Drugs Sales and Growth Rate (2013-2018)

9.2 Middle East and Africa 3D Printed Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)

9.2.1 Middle East and Africa 3D Printed Drugs Sales by Manufacturers (2016-2017)

9.2.2 Middle East and Africa 3D Printed Drugs Revenue by Manufacturers (2016-2017)

9.3 Middle East and Africa 3D Printed Drugs Sales, Revenue and Market Share by Type (2013-2018)

9.3.1 Middle East and Africa 3D Printed Drugs Sales and Sales Share by Type (2013-2018)

9.3.1 Middle East and Africa 3D Printed Drugs Revenue and Revenue Share by Type (2013-2018)

9.4 Middle East and Africa 3D Printed Drugs Sales, Revenue and Market Share by Application (2013-2018)

9.4.1 Middle East and Africa 3D Printed Drugs Sales and Sales Share by Application (2013-2018)

9.4.2 Middle East and Africa 3D Printed Drugs Revenue and Revenue Share by Application (2013-2018)

10 Global 3D Printed Drugs Market Segment by Type

10.1 Global 3D Printed Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global 3D Printed Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global 3D Printed Drugs Revenue and Market Share by Type (2013-2018)

10.2 Spritam Sales Growth and Price

10.2.1 Global Spritam Sales Growth (2013-2018)

10.2.2 Global Spritam Price (2013-2018)

10.3 Others Sales Growth and Price

10.3.1 Global Others Sales Growth (2013-2018)

10.3.2 Global Others Price (2013-2018)

11 Global 3D Printed Drugs Market Segment by Application

11.1 Global 3D Printed Drugs Sales Market Share by Application (2013-2018)

11.2 Children Sales Growth (2013-2018)

11.3 Elderly Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 3D Printed Drugs Market Forecast (2018-2023)

12.1 Global 3D Printed Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 3D Printed Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America 3D Printed Drugs Market Forecast (2018-2023)

12.2.2 Europe 3D Printed Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific 3D Printed Drugs Market Forecast (2018-2023)

12.2.4 South America 3D Printed Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa 3D Printed Drugs Market Forecast (2018-2023)

12.3 3D Printed Drugs Market Forecast by Type (2018-2023)

12.3.1 Global 3D Printed Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global 3D Printed Drugs Market Share Forecast by Type (2018-2023)

12.4 3D Printed Drugs Market Forecast by Application (2018-2023)

12.4.1 Global 3D Printed Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global 3D Printed Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure 3D Printed Drugs Picture

Table Product Specifications of 3D Printed Drugs

Figure Global 3D Printed Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD M

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery